The US Food and Drug Administration (F.D.A.) has given its approval to a new weight-loss medication, Foundayo, developed by pharmaceutical giant Eli Lilly. This breakthrough comes as the global obesity epidemic continues to worsen, with millions of people worldwide struggling to shed excess pounds. Foundayo is an oral medication designed to help individuals achieve and maintain significant weight loss, with the potential to revolutionize the treatment of obesity. The F.D.A.'s approval marks a major milestone in the development of this innovative treatment, which could offer new hope to those battling weight-related health issues.
F.D.A. Approves New Eli Lilly Weight-Loss Pill, Foundayo - The New York Times The New York Times
